| Lastest Insider Transactions Of Lexeo Therapeutics, Inc. ( LXEO ) |
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| LXEO | Lexeo Therapeutics, Inc. | Otero Jose Manuel | Chief Operating Officer | 2026-08-18 | Sell | 1,304 | 4.96 | 6,464 | 2026-08-19 17:00:08 |
| LXEO | Lexeo Therapeutics, Inc. | Tamayo Louis Edward | Chief Financial Officer | 2026-06-29 | Sell | 4,641 | 4.49 | 20,838 | 2026-07-01 18:49:38 |
| LXEO | Lexeo Therapeutics, Inc. | Otero Jose Manuel | Chief Operating Officer | 2026-06-29 | Sell | 4,666 | 4.48 | 20,904 | 2026-07-01 18:49:07 |
| LXEO | Lexeo Therapeutics, Inc. | Bhalla Narinder Pal | Chief Medical Officer | 2026-06-29 | Sell | 22,306 | 4.42 | 98,593 | 2026-07-01 18:48:24 |
| LXEO | Lexeo Therapeutics, Inc. | Townsend Richard Nolan | Chief Executive Officer | 2026-06-29 | Sell | 25,947 | 4.48 | 116,243 | 2026-07-01 18:47:19 |
| LXEO | Lexeo Therapeutics, Inc. | Townsend Richard Nolan | Chief Executive Officer | 2026-04-06 | Sell | 55,000 | 5.69 | 313,137 | 2026-04-07 16:55:07 |
| LXEO | Lexeo Therapeutics, Inc. | Otero Jose Manuel | Chief Operating Officer | 2026-02-18 | Sell | 3,016 | 6.40 | 19,294 | 2026-02-20 17:05:09 |
| LXEO | Lexeo Therapeutics, Inc. | Townsend Richard Nolan | Chief Executive Officer | 2026-02-18 | Sell | 10,173 | 6.38 | 64,924 | 2026-02-20 17:05:07 |
| LXEO | Lexeo Therapeutics, Inc. | Otero Jose Manuel | Chief Operating Officer | 2025-11-18 | Sell | 721 | 9.27 | 6,684 | 2026-02-20 17:05:04 |
| LXEO | Lexeo Therapeutics, Inc. | Townsend Richard Nolan | Chief Executive Officer | 2025-11-18 | Sell | 1,127 | 9.27 | 10,447 | 2025-11-20 17:21:29 |
| LXEO | Lexeo Therapeutics, Inc. | Townsend Richard Nolan | Chief Executive Officer | 2025-11-18 | Sell | 1,127 | 9.27 | 10,447 | 2025-11-20 17:21:29 |
| LXEO | Lexeo Therapeutics, Inc. | Adler Eric | Chief Medical Officer | 2025-11-18 | Sell | 615 | 9.27 | 5,701 | 2025-11-20 17:20:13 |
| LXEO | Lexeo Therapeutics, Inc. | See Tai Sandi | Chief Development Officer | 2025-11-18 | Sell | 386 | 9.27 | 3,578 | 2025-11-20 17:19:10 |
| LXEO | Lexeo Therapeutics, Inc. | Robertson Jenny | Chief Legal Officer | 2025-11-18 | Sell | 549 | 9.27 | 5,089 | 2025-11-20 17:18:07 |
| LXEO | Lexeo Therapeutics, Inc. | Otero Jose Manuel | Chief Technical Officer | 2025-11-18 | Sell | 721 | 9.27 | 6,684 | 2025-11-20 17:14:54 |
| LXEO | Lexeo Therapeutics, Inc. | See Tai Sandi | Chief Development Officer | 2025-10-15 | Sell | 3,888 | 8.94 | 34,767 | 2025-10-17 19:29:33 |
| LXEO | Lexeo Therapeutics, Inc. | See Tai Sandi | Chief Development Officer | 2025-10-15 | Sell | 3,888 | 8.94 | 34,767 | 2025-10-17 19:29:33 |
| LXEO | Lexeo Therapeutics, Inc. | Robertson Jenny | Chief Legal Officer | 2025-10-15 | Sell | 3,526 | 8.94 | 31,530 | 2025-10-17 19:28:53 |
| LXEO | Lexeo Therapeutics, Inc. | Otero Jose Manuel | Chief Technical Officer | 2025-10-15 | Sell | 2,115 | 8.94 | 18,913 | 2025-10-17 19:28:16 |
| LXEO | Lexeo Therapeutics, Inc. | Adler Eric | Chief Medical Officer | 2025-10-15 | Sell | 3,382 | 8.94 | 30,242 | 2025-10-17 19:26:52 |
| LXEO | Lexeo Therapeutics, Inc. | Townsend Richard Nolan | Chief Executive Officer | 2025-10-15 | Sell | 13,133 | 8.94 | 117,436 | 2025-10-17 19:26:05 |
| LXEO | Lexeo Therapeutics, Inc. | Townsend Richard Nolan | Chief Executive Officer | 2025-08-18 | Sell | 1,115 | 4.67 | 5,205 | 2025-09-10 16:59:33 |
| LXEO | Lexeo Therapeutics, Inc. | Townsend Richard Nolan | Chief Executive Officer | 2025-08-18 | Sell | 1,115 | 4.67 | 5,205 | 2025-09-10 16:59:33 |
| LXEO | Lexeo Therapeutics, Inc. | Otero Jose Manuel | Chief Technical Officer | 2025-08-18 | Sell | 2,848 | 4.67 | 13,294 | 2025-08-20 17:05:06 |
| LXEO | Lexeo Therapeutics, Inc. | Robertson Jenny | Chief Legal Officer | 2025-08-18 | Sell | 542 | 4.67 | 2,530 | 2025-08-20 17:03:45 |
| LXEO | Lexeo Therapeutics, Inc. | Adler Eric | Chief Medical Officer | 2025-08-18 | Sell | 608 | 4.67 | 2,838 | 2025-08-20 17:02:15 |
| LXEO | Lexeo Therapeutics, Inc. | Townsend Richard Nolan | Chief Executive Officer | 2025-08-18 | Sell | 2,735 | 4.67 | 12,767 | 2025-08-20 17:00:18 |
| LXEO | Lexeo Therapeutics, Inc. | Townsend Richard Nolan | Chief Executive Officer | 2025-08-18 | Sell | 2,735 | 4.67 | 12,767 | 2025-08-20 17:00:18 |
| LXEO | Lexeo Therapeutics, Inc. | See Tai Sandi | Chief Development Officer | 2025-08-18 | Sell | 382 | 4.67 | 1,783 | 2025-08-20 16:58:23 |
| LXEO | Lexeo Therapeutics, Inc. | Townsend Richard Nolan | Chief Executive Officer | 2025-05-16 | Sell | 1,074 | 2.77 | 2,979 | 2025-05-20 17:00:15 |
| LXEO | Lexeo Therapeutics, Inc. | Adler Eric | Chief Medical Officer | 2025-05-16 | Sell | 585 | 2.77 | 1,623 | 2025-05-20 17:00:14 |
| LXEO | Lexeo Therapeutics, Inc. | Robertson Jenny | Chief Legal Officer | 2025-05-16 | Sell | 521 | 2.77 | 1,445 | 2025-05-20 17:00:12 |
| LXEO | Lexeo Therapeutics, Inc. | See Tai Sandi | Chief Development Officer | 2025-05-16 | Sell | 367 | 2.77 | 1,018 | 2025-05-20 17:00:11 |
| LXEO | Lexeo Therapeutics, Inc. | Townsend Richard Nolan | Chief Executive Officer | 2025-02-19 | Sell | 4,326 | 4.41 | 19,091 | 2025-02-21 17:10:25 |
| LXEO | Lexeo Therapeutics, Inc. | See Tai Sandi | Chief Development Officer | 2025-02-19 | Sell | 1,486 | 4.41 | 6,558 | 2025-02-21 17:09:42 |
| LXEO | Lexeo Therapeutics, Inc. | Adler Eric | Chief Medical Officer | 2025-02-19 | Sell | 2,359 | 4.41 | 10,410 | 2025-02-21 17:09:13 |
| LXEO | Lexeo Therapeutics, Inc. | Robertson Jenny | Chief Legal Officer | 2025-02-19 | Sell | 2,101 | 4.41 | 9,272 | 2025-02-21 17:08:44 |
| LXEO | Lexeo Therapeutics, Inc. | Robertson Jenny | Chief Legal Officer | 2025-02-19 | Sell | 2,101 | 4.41 | 9,272 | 2025-02-21 17:08:44 |
| LXEO | Lexeo Therapeutics, Inc. | Townsend Richard Nolan | Chief Executive Officer | 2024-12-10 | Sell | 2,500 | 8.20 | 20,491 | 2024-12-12 17:00:09 |
| LXEO | Lexeo Therapeutics, Inc. | Townsend Richard Nolan | Chief Executive Officer | 2024-12-10 | Option Exercise | 2,500 | 2.33 | 5,825 | 2024-12-12 17:00:09 |
| LXEO | Lexeo Therapeutics, Inc. | CHOLMONDELEY PAULA H | Directior | 2024-11-25 | Buy | 15,000 | 6.99 | 104,852 | 2024-11-26 17:00:06 |
| LXEO | Lexeo Therapeutics, Inc. | Townsend Richard Nolan | Chief Executive Officer | 2024-11-11 | Sell | 2,500 | 7.82 | 19,557 | 2024-11-13 17:33:29 |
| LXEO | Lexeo Therapeutics, Inc. | Townsend Richard Nolan | Chief Executive Officer | 2024-11-11 | Option Exercise | 2,500 | 2.33 | 5,825 | 2024-11-13 17:33:29 |
| LXEO | Lexeo Therapeutics, Inc. | Townsend Richard Nolan | Chief Executive Officer | 2024-10-10 | Sell | 5,000 | 8.10 | 40,496 | 2024-10-15 13:45:05 |
| LXEO | Lexeo Therapeutics, Inc. | Townsend Richard Nolan | Chief Executive Officer | 2024-10-10 | Option Exercise | 5,000 | 2.33 | 11,650 | 2024-10-15 13:45:05 |
| LXEO | Lexeo Therapeutics, Inc. | Townsend Richard Nolan | Chief Executive Officer | 2024-08-12 | Sell | 5,000 | 11.53 | 57,635 | 2024-08-13 18:34:04 |
| LXEO | Lexeo Therapeutics, Inc. | Townsend Richard Nolan | Chief Executive Officer | 2024-08-12 | Option Exercise | 5,000 | 2.33 | 11,650 | 2024-08-13 18:34:04 |
| LXEO | Lexeo Therapeutics, Inc. | Townsend Richard Nolan | Chief Executive Officer | 2024-07-10 | Sell | 55,000 | 16.79 | 923,388 | 2024-07-12 16:55:07 |
| LXEO | Lexeo Therapeutics, Inc. | Townsend Richard Nolan | Chief Executive Officer | 2024-07-10 | Option Exercise | 5,000 | 2.33 | 11,650 | 2024-07-12 16:55:07 |
| LXEO | Lexeo Therapeutics, Inc. | Townsend Richard Nolan | Chief Executive Officer | 2024-06-10 | Sell | 5,000 | 17.65 | 88,264 | 2024-06-12 17:00:06 |
| LXEO | Lexeo Therapeutics, Inc. | Townsend Richard Nolan | Chief Executive Officer | 2024-06-10 | Option Exercise | 5,000 | 2.33 | 11,650 | 2024-06-12 17:00:06 |
| LXEO | Lexeo Therapeutics, Inc. | Townsend Richard Nolan | Chief Executive Officer | 2024-05-13 | Sell | 5,000 | 13.22 | 66,093 | 2024-05-14 16:04:56 |
| LXEO | Lexeo Therapeutics, Inc. | Townsend Richard Nolan | Chief Executive Officer | 2024-05-13 | Option Exercise | 5,000 | 2.33 | 11,650 | 2024-05-14 16:04:56 |
| LXEO | Lexeo Therapeutics, Inc. | Omega Fund VI, L.P. | 10% Owner | 2023-11-07 | Buy | 454,545 | 11.00 | 4,999,995 | 2023-11-09 20:36:25 |
| LXEO | Lexeo Therapeutics, Inc. | Lundbeckfond Invest A/S | 10% Owner | 2023-11-07 | Buy | 227,272 | 11.00 | 2,499,992 | 2023-11-09 20:33:54 |
| LXEO | Lexeo Therapeutics, Inc. | Longitude Capital Partners IV, LLC | 10% Owner | 2023-11-07 | Buy | 454,545 | 11.00 | 4,999,995 | 2023-11-09 20:32:53 |
